Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Fecal Microbiota Transplantation for Irritable Bowel Syndrome

NCT03613545 is registered in ClinicalTrials.gov with Guangzhou First People's Hospital as lead sponsor.

NCT NCT03613545
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03613545 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Fecal Microbiota Transplantation for Irritable Bowel Syndrome
Lead sponsor
Guangzhou First People's Hospital
Phase
Phase 2/3
Overall status
Recruiting
Start date
August 10, 2018
Completion date
December 31, 2030
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fecal microbiota transplantation, irritable bowel syndrome